136 related articles for article (PubMed ID: 29038345)
1. Administering xCT Inhibitors Based on Circadian Clock Improves Antitumor Effects.
Okazaki F; Matsunaga N; Hamamura K; Suzuki K; Nakao T; Okazaki H; Kutsukake M; Fukumori S; Tsuji Y; To H
Cancer Res; 2017 Dec; 77(23):6603-6613. PubMed ID: 29038345
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting xCT Improves 5-Fluorouracil Resistance of Gastric Cancer Induced by CD44 Variant 9 Expression.
Miyoshi S; Tsugawa H; Matsuzaki J; Hirata K; Mori H; Saya H; Kanai T; Suzuki H
Anticancer Res; 2018 Nov; 38(11):6163-6170. PubMed ID: 30396933
[TBL] [Abstract][Full Text] [Related]
3. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function.
Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y
Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the circadian clock gene Bmal1 increases sensitivity to oxaliplatin in colorectal cancer.
Zeng ZL; Luo HY; Yang J; Wu WJ; Chen DL; Huang P; Xu RH
Clin Cancer Res; 2014 Feb; 20(4):1042-52. PubMed ID: 24277452
[TBL] [Abstract][Full Text] [Related]
5. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.
Otsuki Y; Yamasaki J; Suina K; Okazaki S; Koike N; Saya H; Nagano O
Cancer Sci; 2020 Jan; 111(1):127-136. PubMed ID: 31692172
[TBL] [Abstract][Full Text] [Related]
6. High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine.
Wada F; Koga H; Akiba J; Niizeki T; Iwamoto H; Ikezono Y; Nakamura T; Abe M; Masuda A; Sakaue T; Tanaka T; Kakuma T; Yano H; Torimura T
Cancer Sci; 2018 Sep; 109(9):2801-2810. PubMed ID: 29981246
[TBL] [Abstract][Full Text] [Related]
7. Sulfasalazine, a potent suppressor of gastric cancer proliferation and metastasis by inhibition of xCT: Conventional drug in new use.
Zhuang J; Liu X; Yang Y; Zhang Y; Guan G
J Cell Mol Med; 2021 Jun; 25(12):5372-5380. PubMed ID: 33988296
[TBL] [Abstract][Full Text] [Related]
8. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
9. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway.
Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W
Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640
[TBL] [Abstract][Full Text] [Related]
10. Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.
Ye P; Mimura J; Okada T; Sato H; Liu T; Maruyama A; Ohyama C; Itoh K
Mol Cell Biol; 2014 Sep; 34(18):3421-34. PubMed ID: 25002527
[TBL] [Abstract][Full Text] [Related]
11. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM
Cells; 2020 Jul; 9(7):. PubMed ID: 32630312
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines.
Pham AN; Blower PE; Alvarado O; Ravula R; Gout PW; Huang Y
J Pharmacol Exp Ther; 2010 Mar; 332(3):949-58. PubMed ID: 20007406
[TBL] [Abstract][Full Text] [Related]
13. PI3K regulates BMAL1/CLOCK-mediated circadian transcription from the Dbp promoter.
Morishita Y; Miura D; Kida S
Biosci Biotechnol Biochem; 2016 Jun; 80(6):1131-40. PubMed ID: 27022680
[TBL] [Abstract][Full Text] [Related]
14. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma.
Guo W; Zhao Y; Zhang Z; Tan N; Zhao F; Ge C; Liang L; Jia D; Chen T; Yao M; Li J; He X
Cancer Lett; 2011 Dec; 312(1):55-61. PubMed ID: 21906871
[TBL] [Abstract][Full Text] [Related]
15. The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer.
Fuhr L; El-Athman R; Scrima R; Cela O; Carbone A; Knoop H; Li Y; Hoffmann K; Laukkanen MO; Corcione F; Steuer R; Meyer TF; Mazzoccoli G; Capitanio N; Relógio A
EBioMedicine; 2018 Jul; 33():105-121. PubMed ID: 30005951
[TBL] [Abstract][Full Text] [Related]
16. Modeling circadian clock-cell cycle interaction effects on cell population growth rates.
El Cheikh R; Bernard S; El Khatib N
J Theor Biol; 2014 Dec; 363():318-31. PubMed ID: 25152215
[TBL] [Abstract][Full Text] [Related]
17. The role of system Xc
Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
[TBL] [Abstract][Full Text] [Related]
18. Burn injury induces the expression of cystine/glutamate transporter (x(c)(-)) in mouse T cells.
D'Elia M; Patenaude J; Dupras C; Bernier J
Immunol Lett; 2009 Aug; 125(2):137-44. PubMed ID: 19576933
[TBL] [Abstract][Full Text] [Related]
19. xCT increases tuberculosis susceptibility by regulating antimicrobial function and inflammation.
Cai Y; Yang Q; Liao M; Wang H; Zhang C; Nambi S; Wang W; Zhang M; Wu J; Deng G; Deng Q; Liu H; Zhou B; Jin Q; Feng CG; Sassetti CM; Wang F; Chen X
Oncotarget; 2016 May; 7(21):31001-13. PubMed ID: 27129162
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of cystine uptake and inhibition pattern of sulfasalazine in A549 cells.
Okamoto K; Saito Y; Ueda H; Narumi K; Furugen A; Kobayashi M
Biopharm Drug Dispos; 2021 Sep; 42(8):389-392. PubMed ID: 34287957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
